1.The Ability of beta-Cells to Compensate for Insulin Resistance is Restored with a Reduction in Excess Growth Hormone in Korean Acromegalic Patients.
Soo Kyoung KIM ; Sunghwan SUH ; Ji In LEE ; Kyu Yeon HUR ; Jae Hoon CHUNG ; Moon Kyu LEE ; Yong Ki MIN ; Jae Hyeon KIM ; Jong Hyun KIM ; Kwang Won KIM
Journal of Korean Medical Science 2012;27(2):177-183
The aim of this study was to assess the prevalence of diabetes and to study the effects of excess growth hormone (GH) on insulin sensitivity and beta-cell function in Korean acromegalic patients. One hundred and eighty-four acromegalic patients were analyzed to assess the prevalence of diabetes, and 52 naive acromegalic patients were enrolled in order to analyze insulin sensitivity and insulin secretion. Patients underwent a 75 g oral glucose tolerance test with measurements of GH, glucose, insulin, and C-peptide levels. The insulin sensitivity index and beta-cell function index were calculated and compared according to glucose status. Changes in the insulin sensitivity index and beta-cell function index were evaluated one to two months after surgery. Of the 184 patients, 17.4% were in the normal glucose tolerance (NGT) group, 45.1% were in the pre-diabetic group and 37.5% were in the diabetic group. The insulin sensitivity index (ISI0,120) was significantly higher and the HOMA-IR was lower in the NGT compared to the diabetic group (P = 0.001 and P = 0.037, respectively). The ISI0,120 and disposition index were significantly improved after tumor resection. Our findings suggest that both insulin sensitivity and beta-cell function are improved by tumor resection in acromegalic patients.
Acromegaly/*diagnosis/etiology/metabolism
;
Adult
;
Asian Continental Ancestry Group
;
Blood Glucose/analysis
;
C-Peptide/analysis
;
Diabetes Mellitus/epidemiology
;
Female
;
Glucose Tolerance Test
;
Human Growth Hormone/secretion
;
Humans
;
Insulin/blood/secretion
;
*Insulin Resistance
;
Insulin-Secreting Cells/cytology/*physiology
;
Male
;
Middle Aged
;
Prediabetic State/epidemiology
;
Republic of Korea
2.Change in Somatostatinergic Tone of Acromegalic Patients according to the Size of Growth Hormone-Producing Pituitary Tumors.
Sang Ouk CHIN ; Suk CHON ; You Cheol HWANG ; In Kyung JEONG ; Seungjoon OH ; Sung Woon KIM
Journal of Korean Medical Science 2013;28(12):1774-1780
The aim of this study was to investigate the relationship between somatostatinergic tone (SST) and the size of growth hormone (GH)-producing pituitary tumors. GH levels of 29 patients with newly diagnosed acromegaly were measured using a 75-gram oral glucose tolerance test (OGTT), an insulin tolerance test (ITT), and an octreotide suppression test (OST). Differences between GH levels during the ITT and the OGTT (DeltaGH(IO)), and between the OGTT and the OST at the same time point (DeltaGH(OS)) were compared according to the size of the tumor and the response pattern to the OST. DeltaGH(IO) of macroadenomas (n=22) was non-significantly higher than those of microadenomas while DeltaGH(OS) of macroadenomas were significantly higher than those of microadenomas. According to further analyses of macroadenomas based on the response pattern to the OST, GH levels during the ITT were significantly higher in non-responders. DeltaGH(OS) showed near-significant differences between responders and non-responders. In conclusion, as the size of the pituitary tumor increases, the effect of glucose on SST appears to be attenuated. Macroadenomas that are non-responders to the OST possess a portion of GH secretion exceeding the range of regulation by SST.
Acromegaly/*diagnosis/*pathology
;
Adenoma/drug therapy/*pathology
;
Adult
;
Aged
;
Antineoplastic Agents, Hormonal/therapeutic use
;
Female
;
Glucose Tolerance Test
;
Human Growth Hormone/*blood/secretion
;
Humans
;
Insulin/blood
;
Insulin-Like Growth Factor I/analysis
;
Male
;
Middle Aged
;
Octreotide/therapeutic use
;
Pituitary Neoplasms/drug therapy/*pathology